Prospective Ascertainment for Late Effects Among Cancer Survivors

Protocol
12-143
Full Title
Prospective Ascertainment for Late Effects Among Survivors of Cancer, Tumor, or a Related Illness
Purpose

Some people treated for cancer as children or young adults have an increased risk of heart problems, breathing difficulties, bone problems, and second cancers later on, which may be due to their treatment. These secondary problems are called “late effects.” Researchers want to learn more about the influence of genetic factors (inherited from one’s family) on the risk for late effects.

The purpose of this study is to establish a registry of cancer survivors to improve our understanding of the influence of genetics on late effects following cancer treatment. Participants will provide a saliva or blood sample for genetic analysis and will complete a family medical history questionnaire.

Eligibility

This study includes cancer survivors who are now age 18 or older and are followed at Memorial Sloan-Kettering Cancer Center.

For more information about this study, please contact Dr. Emily Tonorezos at 646-888-4730.

Disease(s)
Survivorship
Locations